Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tara Huston

Plastic and Reconstructive Surgery Stony Brook, NY Medical Doctor

NPI 1811154586 CMS profile 309395

Hsc T19 060, Stony Brook, NY 11794

Open in the dashboard

General payments

$95,313

152 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tara Huston of Stony Brook, NY is reported in the CMS Open Payments database as having received $95,313 across 152 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $61,810 71
2024 General $26,680 36
2023 General $5,916 27
2022 General $16 1
2021 General $348 5
2020 General $88 4
2019 General $453 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tara Huston
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Tara Huston were reported at $61,810. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Tara Huston Plastic and Reconstructive Surgery median Middle half National median
2019 $453 $335 $121–$1,264 $163
2020 $88 $162 $57–$417 $114
2021 $348 $245 $89–$735 $132
2022 $16 $325 $120–$932 $149
2023 $5,916 $343 $129–$999 $160
2024 $26,680 $390 $141–$1,085 $164
2025 $61,810 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $76,921 79 payments
  2. RTI Surgical, Inc $5,700 4 payments
  3. Motiva USA, LLC $3,966 7 payments
  4. Integra LifeSciences Corporation $3,716 8 payments
  5. AxoGen $2,297 10 payments
  6. W. L. Gore & Associates, Inc. $700 1 payment
  7. Smith+Nephew, Inc. $322 15 payments
  8. Avita Medical Americas, LLC $283 2 payments
  9. Allergan Inc. $244 3 payments
  10. Regeneron Healthcare Solutions, Inc. $206 2 payments
  11. Other $957 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $64,025 14 payments
  2. Travel and Lodging $11,191 25 payments
  3. Consulting Fee $10,715 5 payments
  4. Food and Beverage $6,594 105 payments
  5. Honoraria $2,700 2 payments
  6. Gift $87 1 payment
Products named General payments · program years 2019–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS $76,051 66 payments
  2. CORTIVA ALLOGRAFT DERMIS $5,700 4 payments
  3. Motiva Implant Matrix $3,966 7 payments
  4. SURGIMEND $3,540 2 payments
  5. CODMAN CERTAS $3,540 2 payments
  6. Avance Nerve Graft $2,247 9 payments
  7. AXOGUARD NERVE PROTECTOR $2,214 8 payments
  8. AxoGuard Nerve Connector $2,214 8 payments
  9. ALLODERM $733 12 payments
  10. Product in Development $700 1 payment
  11. Other $4,081 87 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$172,403

Medicare's payments for the services billed

Medicare patients

202

Average age 73

Services billed

674

134 women, 68 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 45%
Cancer 40%
Ischemic heart disease 33%
Diabetes 29%
Osteoporosis 23%
Depression 18%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

152 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record